Rasagilins farmakokinetiske egenskaber hos forsøgspersoner med let (CLcr 50- 80 ml/ min) og moderat (CLcr 30- 49 ml/ min) nedsat nyrefunktion var de samme, som sås hos raske forsøgspersoner.
Rasagiline's pharmacokinetics characteristics in subjects with mild (CLcr 50-80 ml/ min) and moderate (CLcr 30-49 ml/ min) renal impairment were similar to healthy subjects.